Titan Spine names Bird as CCO, expands sales team
Titan Spine said it named orthopedics veteran Ted Bird to be its chief commercial officer.
Bird’s resume includes executive stints at Orthofix (NSDQ:OFIX), Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Spine and Medtronic (NYSE:MDT). Most recently Bird was non-executive chairman at APiFix and president of consulting firm Bird Medical.
“Ted is a well-respected medical device commercial leader with more than 30 years of sales, marketing and senior executive experience at leading healthcare companies. He is well-known and highly regarded in the spine industry, with extensive relationships among surgeons and distributors built from over 25 years working with spine companies including ApiFix, Orthofix, Depuy Spine and Medtronic Sofamor Danek. We look forward to Ted’s significant spine commercialization expertise and contributions,” CEO Peter Ullrich said in prepared remarks.
“I am incredibly excited and honored to be joining the Titan Spine team. The company has been at the forefront of moving the interbody device marketplace away from PEEK and towards titanium surface-enhanced implants for improved patient outcomes with validated, peer-reviewed science and strong support from surgeons, hospitals and the U.S. government. I look forward to working closely with the talented team at Titan Spine to continue building on the positive momentum that the company continues to generate and help lead the next phase of the company’s evolution and growth,” Bird added.
In a separate release, Titan Spine said it doubled its sales team, adding 9 new members.
“The addition of 9 new sales managers, all of which bring a tremendous amount of spine sales experience and success, was required to meet accelerating demand for our surface technology offerings. They will play a critical role in working closely with our distribution network partners across the U.S. to further drive surgeon adoption, to support the recent full launch of NanoLock, and to capitalize on the dramatically increased access to surgeons and hospital systems our recently-awarded Section X new technology code from CMS affords us. Our sales expansion initiative is ongoing and is made possible, in large part, from proceeds from our recent substantial round of financing with investor Southlake Equity Group,” sales vice president Steve Cichy said in a statement.
CardioFocus names Bouktari as CCO, taps Rynbrandt for sales veep
Bouknight
CardioFocus said it named Omari Bouknight as chief commercial officer and Jeff Rynbrandt as VP of U.S. sales.
Bouknight was VP of sales & marketing for Cardiac Dimensions and put in time at Thoratec and Guidant. Rynbrandt spent 14 years at Boston Scientific (NYSE:BSX).
“We are excited to bring onto our commercial team 2 highly successful leaders in the cardiology industry. Omari and Jeff bring a combined 30 years of experience leading commercial cardiology launches and sales to CardioFocus. They will be building a revenue ramp from targeted sales of the HeartLight System in the U.S. AF market, which is growing at nearly 20% annually. There are more than 3 million people in the U.S. and more than 33 million worldwide who suffer from AF, and we expect this number to increase given the growing elderly population. HeartLight is very well positioned to assist physicians that treat these patients,” chairman Paul LaViolette said in prepared remarks.
Ex-Delcath CCO Gago joins InspireMD
“I am excited to welcome Agustin to the InspireMD team,” CEO James Barry said in prepared remarks. “Agustin brings a wealth of experience in building and leading global commercial organizations. He will be an invaluable asset to InspireMD as we focus on expanding company sales in the global market place. His successful track record and comprehensive expertise in cardiology, oncology and diagnostic imaging will strengthen our sales and marketing organization. Agustin will be a key addition to our management team as we focus on revenue growth and broadening our product pipeline.”
In addition to Delcath, Gago was a VP at AngioDynamics (NSDQ:ANGO) and, most recently, led Dash International, the consulting firm he founded in 2013.
“I am pleased to be joining InspireMD, a company whose cutting-edge technology and products have the potential to truly be a game changer for patients with carotid artery, neurovascular and coronary artery disease,” Gago said. “I look forward to working with my new team to advance InspireMD’s position and products within the Global market place.”
Hurley tapped for new Ocular Therapeutix CCO spot
Hurley was VP of sales & marketing at Dyax until its acquisition by Shire (NSDQ:SHPGY) in January.
“Andy brings extensive commercial strategy and product launch expertise as well as a proven ability to develop and lead commercialization efforts globally,” president & CEO Amar Sawhney said in prepared remarks. “Andy’s experience will be extremely valuable as we continue to prepare for the potential launch of our lead product candidate, Dextenza, where our objective is to maximize product uptake and revenue from the outset. If approved by the FDA, we believe Dextenza would be the first extended release steroid containing no preservatives available to ophthalmologists that would provide the complete course of therapy with a single placement.”
“I am excited to join Ocular Therapeutix at such an important juncture for the company as it prepares for the potential commercialization of Dextenza,” Hurley said. “I look forward to working with the world class team at Ocular to launch and commercialize Dextenza as well as the company’s additional innovative, extended release product candidates across diverse indications in ophthalmology.”
EnteroMedics CCO Shikora steps down
Shikora, who EnteroMedics said agreed to serve as an hourly consultant, is an associate professor of surgery at Harvard Medical School and the director of the Center for Metabolic & Bariatric Surgery at Boston’s Brigham & Women’s Hospital. He joined EnteroMedics full-time in April 2015.
Going forward, Dr. Shikora has agreed to be available to serve as a consultant to the Company on an hourly basis, as needed.
The post Titan Spine names Bird as CCO, expands sales team | Personnel Moves, Nov. 17, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/2flb9Ie
Cap comentari:
Publica un comentari a l'entrada